Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEurocell Regulatory News (ECEL)

Share Price Information for Eurocell (ECEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 128.50
Bid: 127.00
Ask: 130.00
Change: -0.50 (-0.39%)
Spread: 3.00 (2.362%)
Open: 128.50
High: 128.50
Low: 128.50
Prev. Close: 129.00
ECEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to Trading on London Stock Exchange

9 Mar 2015 08:00

RNS Number : 8727G
Eurocell plc
09 March 2015
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA ("UNITED STATES"), AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND, JAPAN OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DISTRIBUTE THIS ANNOUNCEMENT.

09 March 2015

 

Eurocell plc

Admission to Trading on the London Stock Exchange

 

Further to its announcement on 4 March 2015, Eurocell plc is pleased to announce that its entire ordinary share capital of 100,000,000 ordinary shares has today been admitted to the premium listing segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities under the ticker "ECEL".

 

 

Enquiries

 

Eurocell plc

Patrick Bateman, Chief Executive Officer

Matthew Edwards, Chief Financial Officer

 

+44 177 384 2100

Canaccord Genuity (Sponsor and sole bookrunner)

Bruce Garrow

Colin Christie

Piers Coombs

Chris Connors

 

+44 207 523 8350

Peel Hunt (Co-lead manager)

Dan Webster

Jock Maxwell Macdonald

Richard Brown

+44 207 418 8900

 

Rothschild (Financial adviser)

Jonathan Finn

Greg Cant

 

+44 207 280 5000

Pendomer

Ben Foster

 

+44 20 3603 5221

 

 

 

Important notice

The contents of this announcement, which has been prepared by and is the sole responsibility of the Company, have been approved by Canaccord Genuity Limited solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000, as amended.

The information contained in this announcement is for background purposes only and does not purport to be full or complete. No reliance may be placed for any purpose on the information contained in this announcement or its accuracy, fairness or completeness.

This announcement is an advertisement and not a prospectus and investors should not purchase or subscribe for any securities referred to in this announcement except on the basis of information in the Prospectus to be published by the Company in due course in connection with the proposed admission of the Shares to the premium listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities.

This announcement is not for publication or distribution, in whole or in part, directly or indirectly, in or into the United States (including its territories and possessions, any State of the United States and the District of Columbia), Australia, Canada, the Republic of Africa, New Zealand, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws of such jurisdiction. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy or subscribe for, the securities referred to herein to any person in any jurisdiction, including the United States, Australia, Canada, the Republic of South Africa, New Zealand, or Japan or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

The securities referred to herein may not be offered or sold, directly or indirectly, in the United States unless registered under the US Securities Act of 1933, as amended (the "US Securities Act") or offered in a transaction exempt from, or not subject to, the registration requirements of the US Securities Act. The offer and sale of securities referred to herein has not been and will not be registered under the US Securities Act or under the applicable securities laws of Australia, Canada, the Republic of South Africa, New Zealand, or Japan. There will be no public offer of the Shares in the United States, Australia, Canada, the Republic of South Africa, New Zealand, or Japan. Subject to certain exceptions, the Shares referred to herein may not be offered or sold in Australia, Canada, the Republic of South Africa, New Zealand, or Japan or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, the Republic of South Africa, New Zealand or Japan.

This announcement is only addressed to and directed at persons in member states of the European Economic Area ("EEA") who are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive (Directive 2003/71/EC), as amended ("Qualified Investors").

 

Canaccord Genuity Limited and Peel Hunt LLP, each of which is authorised and regulated by the Financial Conduct Authority in the United Kingdom are acting exclusively for the Company and no-one else in connection with the IPO. They will not regard any other person as their respective clients in relation to the IPO and will not be responsible to anyone other than the Company for providing the protections afforded to their respective clients, nor for providing advice in relation to the IPO, the contents of this announcement or any transaction, arrangement or other matter referred to herein.

In connection with the IPO, each of the Banks and any of their respective affiliates, acting as investors for their own accounts, may purchase Shares and in that capacity may retain, purchase, sell, offer to sell or otherwise deal for their own accounts in such Shares and other securities of the Company or related investments in connection with the IPO or otherwise. Accordingly, references in the Prospectus, once published, to the Shares being offered, acquired, sold, placed or otherwise dealt in should be read as including any offer, sale, acquisition, placing or dealing in the Shares by any of the Banks and any of their affiliates acting as investors for their own accounts. In addition, certain of the Banks or their affiliates may enter into financing arrangements and swaps in connection with which they or their affiliates may from time to time acquire, hold or dispose of Shares. None of the Banks intends to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligations to do so.

None of Banks or any of their respective directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for/or makes any representation or warranty, express or implied, as to the truth, accuracy or completeness of the information in this announcement (or whether any information has been omitted from the announcement) or any other information relating to the Company, its subsidiaries or associated companies, whether written, oral or in a visual or electronic form, and howsoever transmitted or made available or for any loss howsoever arising from any use of this announcement or its contents or otherwise arising in connection therewith.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDMGGFNLRGKZG
Date   Source Headline
4th Jun 202011:47 amRNSDirector Declaration
26th May 20209:37 amRNSBlock Listing Application
19th May 20208:46 amRNSResult of AGM - Correction
15th May 202011:34 amRNSResult of AGM
14th May 20207:00 amRNSAGM and COVID-19 Update
30th Apr 20205:09 pmRNSHolding(s) in Company
17th Apr 202012:55 pmRNSAnnual Financial Report
16th Apr 20205:02 pmRNSHolding(s) in Company
14th Apr 20202:52 pmRNSDirector/PDMR Shareholding
7th Apr 20202:14 pmRNSHolding(s) in Company
3rd Apr 202012:13 pmRNSHolding(s) in Company
1st Apr 20203:22 pmRNSDirector/PDMR Shareholding
1st Apr 20203:21 pmRNSResult of Placing
1st Apr 202011:43 amRNSPlacing of Ordinary Shares
24th Mar 20202:44 pmRNSCOVID-19 Update
13th Mar 20207:00 amRNSPreliminary Results for the year ended 31 Dec 2019
11th Mar 20203:59 pmRNSTransaction in Own Shares
10th Mar 20204:34 pmRNSBlock listing Interim Review
7th Jan 202012:29 pmRNSForm 8.3 - Eurocell PLC
11th Dec 20197:00 amRNSTrading Update
9th Dec 20199:44 amRNSHolding(s) in Company
21st Oct 20191:16 pmRNSHolding(s) in Company
17th Oct 20193:26 pmRNSHolding(s) in Company
17th Oct 20193:11 pmRNSHolding(s) in Company
1st Oct 20197:00 amRNSTotal Voting Rights
20th Sep 20195:33 pmRNSDirector/PDMR Shareholding
5th Sep 20195:49 pmRNSBlock listing Interim Review
14th Aug 20192:55 pmRNSHolding(s) in Company
6th Aug 20191:04 pmRNSHolding(s) in Company
6th Aug 201912:42 pmRNSHolding(s) in Company
2nd Aug 20194:00 pmRNSHolding(s) in Company
2nd Aug 20192:35 pmRNSDirector/PDMR Shareholding
1st Aug 20197:00 amRNSHalf year results for six months ended 30 Jun 2019
9th Jul 201911:27 amRNSHolding(s) in Company
24th Jun 20192:23 pmRNSHolding(s) in Company
24th Jun 201911:31 amRNSHolding(s) in Company
10th May 20194:06 pmRNSResult of AGM
10th May 20197:00 amRNSAGM Trading Update
25th Apr 20193:34 pmRNSDirector/PDMR Shareholding
17th Apr 20197:00 amRNSNotice of AGM
22nd Mar 20192:23 pmRNSTransaction in Own Shares
15th Mar 20197:00 amRNSResults for the year ended 31 December 2018
8th Mar 20197:00 amRNSBlock listing Interim Review
14th Dec 20182:25 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSTrading Update
14th Sep 201810:02 amRNSDirectorate Change
6th Sep 20187:00 amRNSBlock listing Interim Review
13th Aug 20183:12 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSResults for the six months ended 30 June 2018
27th Jun 20184:58 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.